Prostate cancer survivors can improve their sex life at the gym

June 23, 2014
Prue Cormie with patient. Credit: Cohesion Magazine ECU

Perth researchers have shown that twice-weekly exercise can improve sexual function in prostate cancer patients by 50 per cent.

Now, they're calling on Perth to participate in a new study to find out why works, and how effective it can be on a broader range of patients.

One in six Australian men will be diagnosed with prostate cancer, and 90 per cent of them will report some form of sexual dysfunction during or after their treatment.

"Men think about sex a lot – on average, every 45 minutes which is more often than they think about food or sleep," says Dr Prue Cormie, a senior research fellow at Edith Cowan University. "So it's not surprising that sexual dysfunction is the most frequently identified issue of importance among prostate cancer survivors."

Last year, Prue and her colleagues at the Edith Cowan University Health and Wellness Institute put a group of men with prostate cancer through a supervised exercise program involving twice-weekly group-based sessions of resistance exercise such as weight lifting, and aerobic exercises including walking and cycling.

"After three months, the men involved in the exercise program had a 50 per cent greater level of sexual activity, which was largely driven by an increase in sexual desire," says Prue. "We observed significant improvements such as gains in muscle mass, as well as improvements in fatigue, depression, anxiety, strength, fitness and quality of life that we believe contributed to enhancing men's libido."

Not only is exercise effective, but it also offers a more patient-friendly and cost-effective treatment compared with traditional management options such as Viagra, penile implant surgery, or the injection of drugs directly into the penis.

"We've shown that exercise is having a positive effect, so now our next step is to look at a broader range of patients undergoing different prostate cancer treatments to help us explain why," says ECU Health and Wellness Institute co-director, Professor Daniel Galvão.

The team at Edith Cowan University would like to hear from men who are concerned about their sexual wellbeing, who are receiving treatment and/or are within six months since having surgery, finishing radiation therapy or completing hormone therapy for .

"The exercise routine is fairly straightforward," says Mr Lee Giampietro, who participated in the initial study and has chosen to continue exercise treatment. "I'd certainly encourage other men out there to get involved in the next phase of the study to help improve treatment options, and reduce of the big stresses that come with this kind of cancer."

Explore further: Exercise–libido link confirmed in prostate survivors

More information: For more information on the study, see: www.ecuhealthwellnessinstitute … ychosexual-therapies

Related Stories

Exercise–libido link confirmed in prostate survivors

October 23, 2013
In a world first, researchers from Edith Cowan University's Health and Wellness Institute have established a link between exercise and sexual health in men with prostate cancer.

Treatment extends life for men with prostate cancer

June 1, 2014
A new treatment has been shown to extend the lifespans of men with advanced prostate cancer by as much as one year, researchers said Sunday.

Medication does not help prevent ED following radiation therapy for prostate cancer

April 1, 2014
Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in the April 2 issue ...

Care after treatment is 'letting down' men with prostate cancer

October 16, 2013
More than 8 in 10 men living with prostate cancer may not be getting the nursing care they need to prevent possible psychological and sexual problems following treatment, according to a new study published in the British ...

Radiation for prostate cancer linked to secondary cancers, study finds

May 30, 2014
Among men treated for prostate cancer, those who received radiation therapy were more likely to develop bladder or rectal cancer, according to a new study from the University of Michigan Comprehensive Cancer Center.

Exercise linked with reduced prostate cancer risk in Caucasians but not African Americans

February 11, 2013
A new study suggests that exercise may reduce Caucasian men's risk of developing prostate cancer. And among Caucasian men who do have prostate cancer, exercise may reduce their risk of having more serious forms of the disease. ...

Recommended for you

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.